Vaccine policy changes and epidemiology of poliomyelitis in the United States. - Wikidata - awgldk - TriplyDB

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

http://www.wikidata.org/entity/Q35916018

about

Poliomyelitis and the postpolio syndrome Plant-based oral vaccines against zoonotic and non-zoonotic diseases Wanted, dead or alive: New viral vaccines Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.An unusual case of vaccine-associated paralytic poliomyelitis From emergence to eradication: the epidemiology of poliomyelitis deconstructed Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.Polio inactivated vaccine costs into routine childhood immunization in Brazil.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.Novel antigen delivery systems.Translational research in infectious disease: current paradigms and challenges ahead.What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.Human Enteroviruses isolated during acute flaccid paralysis surveillance in Ghana: implications for the post eradication era.Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.Neuroepidemiology and the epidemiology of viral infections of the nervous system Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine.Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes.Future of polio vaccines.Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles A mucosal adjuvant for the inactivated poliovirus vaccine.Neurological complications following vaccinations.Switching from OPV to IPV: are we behind the schedule in Latin America?Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.Review of the risks and benefits of yellow fever vaccination including some new analyses.Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.Preeradication vaccine policy options for poliovirus infection and disease control.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

P2860

Q24555519-37E21CB0-1381-4036-918C-9FDC5F6A9C64 Q26738581-0C4579DB-9688-4ED8-B190-F6DCA6A72DBE Q27489979-F570D073-23CD-4F62-824B-9E8CE740A53D Q31134681-1E3288B6-1646-491D-9072-89FA3978BE49 Q33381395-7477075A-A8D7-415B-9163-48B841D47BEB Q33766951-7D33B643-A704-4198-9C94-3948D3692CE8 Q33827773-95F2CB9F-2CDD-4AB5-B515-536903D73B0D Q34045658-B1BF4AAD-4784-492A-A899-DB9A5A0FF738 Q34238410-E00123DB-5F94-4EBF-917F-7DFBD8BF02B2 Q34349482-33810464-1B66-4153-A102-25D2ACD2262A Q34632088-709F127A-F945-4286-AB91-78FBD4F41124 Q35075110-C107EED1-FF0F-4259-8E4E-32EF1FEE0C29 Q35131980-D53A5161-5451-49A7-A100-1315E6A47245 Q35141448-8779B49C-CE0A-469B-9907-DDAF7CFA6341 Q35281764-3E6F99EA-D2CE-4E78-AB03-7BBE05089D8A Q35779660-DA83B964-7797-40D3-871B-146E649A4E32 Q35779733-0BC5F0A7-D6B2-403C-8973-693BF145E082 Q35947894-C7534C86-D52E-4DCA-87C0-DF12A0EE25AA Q35992621-844CD404-C9C4-4ED3-A7E7-E6BD5F19A533 Q35999835-50DA96BC-2228-442E-9C72-7671885DC28A Q36069274-B82AC728-FD75-42AD-ABB0-626934E93755 Q36325623-CBFD07B0-184E-4978-B9FD-04401AC92D5D Q36364228-17A052D2-6F5D-429B-977C-0BCA37EAB08B Q36518544-963323EC-1C2F-4E2F-AD3B-CBDF1B88834C Q36829670-F9C5A897-14FF-4A7F-8310-9663349136C6 Q36898727-8D089199-9AAD-44EC-98F9-4E545D0665FD Q36899024-B6229989-549C-4641-A48D-7CA52A94A84A Q37324787-A607D79F-2788-4512-AF92-9208CA34B9DB Q37450453-1791CDFC-4DDB-4207-90AB-9300044CE755 Q37473244-A2D99671-40D0-4CE2-8E21-71E72EE56BD5 Q37603633-8877B68F-8ADE-47ED-8FF0-70E9775972E1 Q37668140-811FFD67-31C4-4668-97C0-65419790C03E Q37734630-2629BE82-92E5-43E1-A426-03FC0C2CC44D Q37744977-0C2892F9-8A44-48A1-ABBC-C7F2C8697E9E Q37891602-8D5876A7-4E41-4F0E-AA99-D8C52D3C959C Q37908267-CF884BA8-0F63-40F7-AE98-61CAEBDDEC49 Q38006992-A43E07BD-65E1-41F7-BB48-DE297A6EFDD7 Q38006994-8DD1CD95-CABB-493B-B48E-EBD0D10F9AA7 Q38086593-471E4498-601D-4262-A915-4577E248B44D Q38087428-CCA3B8B1-D860-48AE-BF23-FF86A3326849

P2860

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

http://www.wikidata.org/entity/Q35916018

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@ast

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@en

type

label

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@ast

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@en

prefLabel

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@ast

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@en

P1433

Q35916018-55D44D22-930E-4AFB-9363-7FA68C6CD10E

P1476

Q35916018-6732BB6B-E9D3-46B7-8B08-8848E4A9F831

P2093

Q35916018-068B4245-487E-4774-8DB3-7B7B788A586A

Q35916018-2D6654AC-976C-41E1-A479-BDC4A0C0A24D

Q35916018-453B1579-8E6F-4F14-A7B8-991E0B60C346

Q35916018-5406E695-F1D4-4563-8041-2F59815D04B2

Q35916018-5B6FD754-C074-4F52-AADE-50A20A0DACB2

Q35916018-6401F3E6-31D7-435F-86DA-4DC0DCA43809

Q35916018-B8CEC247-47D2-4852-B5B7-F9A8C51A0507

Q35916018-C238846D-F572-4EDC-8E55-795911CC8545

P304

Q35916018-C376454B-8263-465F-B43C-1371EFCD9893

P31

Q35916018-E70EBEC8-9446-441C-893F-8E54D6755618

P356

Q35916018-EFF915AC-04DB-4421-B0C3-A63959AA9360

P407

Q35916018-B9E1F968-8D0D-4532-AD18-B30075F51D41

P433

Q35916018-AD44D4B1-5678-4E1A-ACB4-8C99465F53AD

P478

Q35916018-AD1AA923-88D1-4D55-AE15-1C180F63E2C7

P50

Q35916018-561243EE-7451-4397-88B9-7D85A397D51E

Q35916018-92ABF9D9-C263-4761-B7CB-8A6140763B7D

Q35916018-BE1742B0-7AD1-4E7A-992A-5C2C8BC4EB43

P577

Q35916018-A107A72A-D4CE-4FEE-AADD-E98E05B146DD

P5875

Q35916018-7C0DAD01-55DC-449E-BB63-3924ED3F5EFA

P698

Q35916018-006AB43A-DBB6-400E-AD9E-5EFB719B60CB

P921

Q35916018-60AE991A-272C-4B3D-9A0D-582416B3BC1F

P356

JAMA.292.14.1696

P1433

Journal of the American Medical Association

P1476

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

@en

P2093

D Rebecca Prevots

http://www.w3.org/2001/XMLSchema#string

Jane F Seward

http://www.w3.org/2001/XMLSchema#string

Joanne Cono

http://www.w3.org/2001/XMLSchema#string

Lorraine Niño Alexander

http://www.w3.org/2001/XMLSchema#string

Olen M Kew

http://www.w3.org/2001/XMLSchema#string

Peter M Strebel

http://www.w3.org/2001/XMLSchema#string

Roland W Sutter

http://www.w3.org/2001/XMLSchema#string

Tammy A Santibanez

http://www.w3.org/2001/XMLSchema#string

P304

1696-1701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.292.14.1696

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

Walter A. Orenstein

Melinda Wharton

Mark A. Pallansch

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8236192

http://www.w3.org/2001/XMLSchema#string

P698

15479934

http://www.w3.org/2001/XMLSchema#string

P921

Bệnh viêm tủy xám